R K Ramanathan, Director

At the young age of 27, Ramanathan began his entrepreneurial journey founding the pharmaceutical company American Remedies, building it into a Rs.100 Crore enterprise as also the 37th largest formulations company in India. In 1999, American Remedies merged with Dr Reddy`s Laboratories. Ramanathan is highly regarded for his ability to spot business opportunities and catch the early waves.

G K Ramani, Director

G K Ramani has been in the pharmaceutical arena for over three decades. As one of American Remedies’ key forces, he gave the company country-wide visibility. An expert who has in-depth knowledge of the industry, and a charismatic leader, he has the credit of having mentored and developed numerous accomplished professionals in this industry.

K R Krishna, Director

Krishna turned angel investor soon after his graduation and has invested in diverse businesses over the past decade. The investments have been into Pharmaceutical, Healthcare & Wellness, Real Estate, Niche Retail & IT. His expertise lies in analyzing businesses not just markets. Krishna’s strategy is based on the tenets of shared entrepreneurial spirit, trustworthy partnership, operational freedom and equitable stakes.

P V Sankar Dass, Director

With over three decades of experience, SankarDass has been an ace strategist, building major brands in the pharma industry, both in India and emerging markets. An all-rounder with skills across sales, marketing, brand management, alliances, acquisitions and also successfully creating a leadership pipeline. Prior to this, he was the VP in Dr. Reddy’s Labs as also, the founder of a consulting firm.

Abhay Pandey, Nominee Director

As Managing Director of Sequoia Capital. he spearheads investments in healthcare, energy and outsourcing sectors. Some of his investments include Moolchand Hospitals and Ind-Bharath Power. Prior to Sequoia Capital, he was head of Real Estate & Infrastructure Investment Banking at DSP Merrill Lynch where he led capital raising, including the largest Indian IPO for DLF Ltd. Previously, Abhay worked at McKinsey & Co, in Mumbai and Johannesburg. He received an MBA from IIM Calcutta and a B. Tech. in CS and Engineering from IIT Bombay. Abhay represents Sequoia, the current investors in Curatio.

Anjana Sasidharan, Nominee Director

Anjana is a Vice President with Sequoia Capital India. Prior to joining Sequoia, Anjana spent four years with McKinsey & Co. At McKinsey, she advised clients across multiple sectors in India on Strategy, as well as Sales & Marketing. Anjana holds an MBA from IIM, Ahmedabad where she was an Aditya Birla Scholar and a BS in Electronics & Communication Engineering from the National Institute of Technology, Tiruchirappalli, where she was a Lucent Global Science Scholar. Anjana represents Sequoia who are the current investors in Curatio.

Sanjiv Kaul, Nominee Director

Sanjiv has been with ChrysCapital since July 2004 and leads the healthcare and consumer sectors. He has 27 years of management experience in the pharmaceuticals industry prior to ChrysCapital, of which the last two decades were with Ranbaxy, one of India’s largest pharmaceutical companies. Sanjiv held several key leadership positions including country head for China, Regional Director for India and the Middle East and the Vice President and Head of Corporate Affairs for Ranbaxy. Sanjiv received an AMP from Harvard Business School, an MBA from Indian Institute of Management, Ahmedabad and is a pharmacy graduate.